0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

JAMA Theme Issue on Infectious Diseases—Call for Papers FREE

Preeti N. Malani, MD, MSJ1,2,3; Michael Berkwits, MD, MSCE4
[+] Author Affiliations
1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor
2Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan
3Associate Editor, JAMA
4Deputy Editor, JAMA
JAMA. 2013;310(23):2509. doi:10.1001/jama.2013.284362.
Text Size: A A A
Published online

Infectious disease is among the most complex and dynamic of all medical specialties, with near-constant change in organisms, drugs, and approaches to patient care. Ironically, while advances in public health have been driven historically by management of infections, the body of evidence that guides contemporary practice in infectious diseases remains relatively limited. Many infection-related threats, such as avian influenza, extensively drug-resistant tuberculosis, and the growth of multidrug-resistant organisms with a lean pipeline for novel anti-infectives, are current concerns. Past outbreaks of SARS, pandemic influenza, Middle East respiratory syndrome coronavirus, and iatrogenic fungal meningitis are reminders that others await and, on arrival, will leave the public health and infectious diseases communities scrambling for solutions only after serious illness results.

In acknowledgment of the fundamental role infectious diseases play in contemporary health care, the JAMA editors are pleased to announce an infectious diseases theme issue for publication in October 2014, at the time of the annual IDWeek meeting. We invite authors to submit manuscripts on any topic related to the epidemiology, diagnosis, treatment, or prevention of infectious diseases. We will consider any category of study and a wide range of topics, but highest priority will be given to original research that is clinically relevant and methodologically sound, especially clinical trials that address novel approaches to treatment and prevention of common infections. Given the timing of publication of the theme issue, we are especially interested in late-breaking clinical trials that will be presented at the IDWeek meeting. Authors involved with such studies are encouraged to contact us as early as possible, both to discuss our interest in the trial and to coordinate timing of manuscript submission with the goal of simultaneous publication at the time of presentation.

Clinical trials rarely can fill a journal issue, and important clinical questions far exceed the number of trials that can be planned, so we invite authors to submit research with other designs and approaches. Translational investigations that have indirect clinical significance by advancing the understanding of pathogenesis and biomolecular aspects of disease will receive careful consideration. Studies that present new information relevant to optimizing treatment strategies and prevention efforts, and those that enhance the understanding of quality-of-life and economic consequences of infection are also of interest. We also invite submission of thought-provoking Viewpoints on timely and potentially controversial topics related to infectious diseases. Manuscripts on topics the research community is especially engaged in—novel antimicrobials, new treatments for viral hepatitis, and immunizations to prevent or modify disease—are welcome. Although human immunodeficiency virus (HIV)–related submissions are also welcome, a separate theme issue on HIV/AIDS is planned for July 2014.

Prospective authors should consult the Instructions for Authors for guidelines on manuscript preparation and submission.1 All submitted manuscripts will undergo the usual process of editorial evaluation and review. High-quality manuscripts not accepted for publication in JAMA may be referred (with the authors’ permission) to one of the JAMA Network journals for further consideration.

Authors who are interested in submitting a manuscript for the infectious diseases theme issue should indicate this on their cover letter accompanying the manuscript. Manuscripts received before April 15, 2014, will have the best chance of consideration for inclusion in the JAMA infectious diseases theme issue. Exceptions to this submission deadline can be made for late-breaking randomized clinical trials if needed.

If authors have any questions about this theme issue or any other issues related to infectious diseases–related submissions to JAMA, please feel free to contact us.

We look forward to receiving your manuscripts for the 2014 infectious diseases theme issue of JAMA.

ARTICLE INFORMATION

Corresponding Author: Preeti N. Malani, MD, MSJ, Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, 3119 Taubman Center, Ann Arbor, MI 48109-5378 (pmalani@umich.edu).

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

JAMA Instructions for Authors. http://jama.jamanetwork.com/public/instructionsForAuthors.aspx. Accessed November 21, 2013.

Figures

Tables

References

JAMA Instructions for Authors. http://jama.jamanetwork.com/public/instructionsForAuthors.aspx. Accessed November 21, 2013.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles